🇺🇸 FDA
Patent

US 8642282

Inhibitors of nitric oxide synthase for treatment of melanoma

granted A61KA61K31/4439A61P

Quick answer

US patent 8642282 (Inhibitors of nitric oxide synthase for treatment of melanoma) held by The Regents of the University of California expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/4439, A61P, A61P35/00